Stay updated with breaking news from Eric karas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA refuses to okay first nasal spray for allergic reactions, firm says washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
The push to make the lifesaving opioid overdose antidote easier to buy took five years and multiple court battles, fueling worries about access and supply.
How Emergent BioSolutions profited from Narcan's over-the-counter delay washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® for the Treatment of Allergic Reactions , Including Anaphylaxis New Drug and Marketing Authorization... | May 15, 2023
ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ARS Pharmaceuticals Appoints Eric Karas as Chief Commercial Officer and Kathleen Scott as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace
Chicago Transit, Ride-Share Companies Say Riders Are Returning Transportation providers in Chicago are noticing that the number of riders is steadily growing. However, some riders argue that their return to public transit depends on their employers' decision to continue telecommuting. by Sarah Freishtat, Chicago Tribune / April 15, 2021 CTA commuters wait for train doors to open at Clark and Lake Street in downtown Chicago, April 14, 2021. Chicago Tribune (TNS) — Chicago’s transportation providers say they’re seeing more customers as COVID-19 vaccinations ramp up and people venture out, but a return to old habits seems unlikely. About 76% of CTA riders and 80% of Metra and Pace users who stopped riding during the pandemic said they would return to public transportation, according to a survey released Thursday by the Regional Transportation Authority.
Transit ridership picks up but return to old habits unlikely chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
CTA, Metra, Uber and Lyft say riders are coming back. But who needs a ride if you're working from home? | State and Regional herald-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from herald-review.com Daily Mail and Mail on Sunday newspapers.